This information is intended for Canadian residents.
Sanofi is a global healthcare company with a broad portfolio of prescription medicines. Comprehensive information about our pharmaceutical products is available below, primarily in the form of product monographs.
This information has been approved by Health Canada and should be reviewed in consultation with a healthcare professional to determine the most appropriate treatment options.
Diabetes
Admelog™ and Admelog™ SoloSTAR®
(insuline lispro injectable)
Rare diseases
Aldurazyme®
(laronidase)
Diabetes
AllStar® Pro
Rare blood disorders
Alprolix®
(coagulation factor IX (recombinant), Fc fusion protein)
Rare blood disorders
Altuviiio®
(Antihemophilic Factor VIII [Recombinant, B-Domain deleted], Fc-VWF-XTEN fusion protein)
Diabetes
Apidra®
(insulin glulisine)
Other
Arava®
(leflunomide)
Cardiovascular diseases
Avalide®
(irbesartan, hydrochlorothiazide)
Cardiovascular diseases
Avapro®
(irbesartan)
Other
Calcimar®
(calcitonin-salmon)
Oncology
Caprelsa®
(vandetanib)
Rare diseases
Cerdelga®
(eliglustat)
Rare diseases
Cerezyme®
(imiglucerase)
Oncology
Clolar®
(clofarabine for injection)
Other
Cyclomen®
(danazol)
Immunology
Dupixent®
(dupilumab)
Rare blood disorders
Eloctate®
(antihemophilic factor (recombinant BDD), Fc fusion protein )
Rare diseases
Fabrazyme®
(agalsidase beta)
Oncology
Fasturtec®
(rasburicase)
Other
Ferrlecit®
(sodium ferric gluconate)
Other
Flagyl®
(metronidazole)
Other
Flagystatin®
(metronidazole, nystatin)
Oncology
Fludara®
(fludarabine phosphate)
Diabetes
Glucophage®
(metformin hydrochloride)
Other
Imovane®
(zopiclone)
Diabetes
JuniorSTAR®
Other
Kayexalate®
(sodium polystyrene sulfonate)
Immunology
Kevzara®
(sarilumab)
Diabetes
Lantus®
(insuline glargine)
Cardiovascular diseases
Lasix® Oral Solution
(furosemide)
Cardiovascular diseases
Lasix® Special
(furosemide)
Neurology
Lemtrada®
(alemtuzumab)
Other
Lovenox® / Lovenox® HP
(enoxaparin sodium)
Oncology
MabCampath®
(alemtuzumab)
Other
Mersyndol® with Codeine
(acetaminophen, codeine phosphate, doxylamine succinate)
Other
Mozobil®
(plerixafor injection)
Cardiovascular diseases
Multaq®
(dronedarone tablets)
Rare diseases
Myozyme®
(alglucosidase alfa)
Rare diseases
Nexviazyme™
(avalglucosidase alfa for injection)
Cardiovascular diseases
Nitrolingual® Pumpspray
Trademark of G. Pohl-Boskamp GmbH & Co. Commercialized in Canada by sanofi-aventis. (nitroglycerin)
Other
Plaquenil®
(hydroxychloroquine sulfate)
Cardiovascular diseases
Plavix®
(clopidogrel bisulfate)
Cardiovascular diseases
Praluent®
(alirocumab)
Other
Primaquine®
(primaquine phosphate)
Other
Renagel®
(sevelamer hydrochloride tablets)
Other
Renvela®
(sevelamer carbonate tablets)
Other
Resonium® Calcium
(calcium polystyrene sulfonate)
Other
Rezurock®
(belumosudil)
Other
Rilutek®
(riluzole)
Oncology
Sarclisa™
(isatuximab for injection)